Geode Capital Management, LLC Novo Cure LTD Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,375,386 shares of NVCR stock, worth $37.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,375,386
Previous 1,643,132
44.56%
Holding current value
$37.1 Million
Previous $25.7 Million
58.44%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$174 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$46.9 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA2.31MShares$36 Million0.01% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.64B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...